No survival benefit from adding cetuximab or panitumumab to oxaliplatin-based chemotherapy in the first-line treatment of metastatic colorectal cancer in KRAS wild type patients: a...

by Si-wei Zhou, Yuan-yuan Huang, Ying Wei, Zhi-min Jiang, Yuan-dong Zhang, Qiong Yang, De-rong Xie
Published 2012-01-01